PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome – Medical Marijuana Program Connection

· Cannabis · By ReportWire
PureTech Awarded up to .4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome – Medical Marijuana Program Connection

BOSTON–(BUSINESS WIRE)–PureTech Awarded up to $11.4 Million from U.S. DOD to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome … Read More

MMP News Author

Source link